medigraphic.com
Instituto Nacional de Salud Pública

2022, Número 4

<< Anterior Siguiente >>

salud publica mex 2022; 64 (4)


Validez y fiabilidad del inventario polidiagnóstico para trastornos psicóticos OPCRIT 4.0 adaptado al español

Martínez-Leal R, Soriano M, Salvador-Carulla L, Folch-Mas A

Idioma: Español
Referencias bibliográficas: 39
Paginas: 406-414
Archivo PDF: 324.52 Kb.


RESUMEN

Objetivo. Adaptar y validar al español el Inventario de Criterios Operativos Diagnósticos (OPCRIT 4.0) para trastornos psicóticos. Se trata de una herramienta que permite diagnosticar a un paciente mediante las principales clasificaciones diagnósticas. Material y métodos. Se realizó la traducción y retrotraducción del inventario original en inglés al español y se comprobó la validez de criterio, la validez concurrente y la fiabilidad interevaluador del mismo, a partir de una muestra de 106 historias clínicas de usuarios adultos de un centro de salud mental comunitario. Resultados. Los datos obtenidos demostraron la validez y fiabilidad de la adaptación del OPCRIT 4.0 en la evaluación de la muestra de historias clínicas. Conclusiones. La adaptación y validación al español del instrumento OPCRIT 4.0 permite disponer de un sistema rápido, fiable y útil para obtener el diagnóstico del trastorno psicótico en un paciente a través de diferentes sistemas de clasificación.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Dennison CA, Legge SE, Pardiñas AF, Walters JTR. Genome-wideassociation studies in schizophrenia: Recent advances, challenges andfuture perspective. Schizophrenia Research. 2020;217:4-12. https://doi.org/10.1016/j.schres.2019.10.048

  2. Forsyth JK, Asarnow RF. Genetics of Childhood-onset Schizophrenia2019 Update. Child Adolesc Psychiatr Clin N Am. 2020;29:157-70. https://doi.org/10.1016/j.chc.2019.08.007

  3. Seidman LJ, Mirsky AF. Evolving notions of schizophrenia as a developmentalneurocognitive disorder. J Int Neuropsychol Soc. 2017;23:881-92.https://doi.org/10.1017/S1355617717001114

  4. Al-Diwani AAJ, Pollak TA, Irani SR, Lennox BR. Psychosis: an autoimmunedisease? Immunology. 2017;152:388-401. https://doi.org/10.1111/imm.12795

  5. Kroken RA, Sommer IE, Steen VM, Dieset I, Johnsen E. Constructing theimmune signature of schizophrenia for clinical use and research; an integrativereview translating descriptives into diagnostics. Front Psychiatry.2019;31:753. https://doi.org/10.3389/fpsyt.2018.00753

  6. Van Kesteren CFMG, Gremmels H, De Witte LD, Hol EM, Van Gool AR,Falkai PG, et al. Immune involvement in the pathogenesis of schizophrenia:A meta-analysis on postmortem brain studies. Transl Psychiatry.2017;7:e1075. https://doi.org/10.1038/tp.2017.4

  7. Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, PhiphopthatsaneeN, Amir T, et al. What causes psychosis? An umbrella review of riskand protective factors. World Psychiatry. 2018;17:49-66. https://doi.org/10.1002/wps.20490

  8. Dean B, Copolov D, Scarr E. Understanding the pathophysiology ofschizophrenia: Contributions from the Melbourne Psychiatric BrainBank. Schizophrenia Research. 2016;177:108-14. https://doi.org/10.1016/j.schres.2016.04.037

  9. Foley C, Corvin A, Nakagome S. Genetics of Schizophrenia: Ready toTranslate? Curr Psychiatry Rep. 2017;19:61. https://doi.org/10.1007/s11920-017-0807-5

  10. Misiak B, Stramecki F, Gawęda Ł, Prochwicz K, Sąsiadek MM, MoustafaAA, Frydecka D. Interactions between variation in candidate genesand environmental factors in the etiology of schizophrenia and bipolardisorder: a systematic review. Molecular Neurobiology. 2018;55:5075-100.https://doi.org/10.1007/s12035-017-0708-y

  11. Zwicker A, Denovan-Wright EM, Uher R. Gene-environment interplayin the etiology of psychosis. Psychological Medicine. 2018;48:1925-36.https://doi.org/10.1017/S003329171700383X

  12. Migdalska-Richards A, Mill J. Epigenetic studies of schizophrenia:current status and future directions. Curr Opin Behav Sci. 2019;25:102-10.https://doi.org/10.1016/j.cobeha.2018.12.003

  13. Jablensky A. The diagnostic concept of schizophrenia: its history, evolution,and future prospects. Dialogues Clin Neurosci. 2010;12:271-87.

  14. Möller H. Is schizophrenia still one entity with similar symptomaticpatterns, neurobiological characteristics, and treatment perspectives? EurArch Psychiatry Clin Neurosci. 2018;268:525-7. https://doi.org/10.1007/s00406-018-0926-y

  15. Merritt J, Tanguturi Y, Fuchs C, Cundiff A. W. medical etiologies ofsecondary psychosis in children and adolescents. Child Adolesc PsychiatrClin N Am. 2020;29:29-42. https://doi.org/10.1016/j.chc.2019.08.005

  16. Kircher T, Wöhr M, Nenadic I, Schwarting R, Schratt G, Alferink J, et al.Neurobiology of the major psychoses: a translational perspective on brainstructure and function—the FOR2107 consortium. Eur Arch Psychiatry ClinNeurosci. 2019;269:949-62. https://doi.org/10.1007/s00406-018-0943-x

  17. Tandon R, Gaebel W, Barch DM, Bustillo J, Gur RE, Heckers S,et al. Definition and description of schizophrenia in the DSM-5.Schizophrenia Research. 2013;150(1):3-10. https://doi.org/10.1016/j.schres.2013.05.028

  18. Maj M. Critique of the DSM-IV operational diagnostic criteria forschizophrenia. Br J Psychiatry. 1998;172:458-60. https://doi.org/10.1192/BJP.172.6.458

  19. Peralta V, Cuesta MJ. Clinical models of schizophrenia: a criticalapproach to competing conceptions. Psychopathology. 2000;33:252-8.https://doi.org/10.1159/000029154

  20. Kendler KS. Phenomenology of schizophrenia and the representativenessof modern diagnostic criteria. JAMA Psychiatry. 2016;73:1082-92.https://doi.org/10.1001/jamapsychiatry.2016.1976

  21. Peralta V, Goldberg X, Ribeiro M, Sanchez-Torres AM, Fañanás L,Cuesta MJ. Familiality of psychotic disorders: A polynosologic study inmultiplex families. Schizophr Bull. 2016;42:975-83. https://doi.org/10.1093/schbul/sbv192

  22. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operationalcriteria in studies of psychotic illness. Development and reliability ofthe OPCRIT system. Arch Gen Psychiatr. 1991;48:764-70.

  23. Cardno AG, Jones LA, Murphy KC, Asherson P, Scott LC, WilliamsJ, et al. Factor analysis of schizophrenic symptoms using the OPCRITchecklist. Schizophrenia Research. 1996;22:233-9. https://doi.org/S0920996496000606

  24. Brittain PJ, Stahl D, Rucker J, Kawadler J, Schumann G. A review of thereliability and validity of OPCRIT in relation to its use for the routineclinical assessment of mental health patients. Int J Methods Psychiatr Res.2013;22:110-37. https://doi.org/10.1002/mpr.1382

  25. Farmer AE, Jones I, Williams J, McGuffin P. Defining schizophrenia:Operational criteria. J Ment Health. 1993;2:209-22. https://doi.org/10.3109/09638239309003767

  26. Oliveira L, Pereira A, Nogueira V, Soares MJ, Valente J, Dourado A, etal. Symptom dimensions of psychosis – opcrit factorial analysis of a largesample of portuguese psychotic patients. Eur Psychiatry. 2015;30:349.https://doi.org/10.1016/S0924-9338(15)30274-1

  27. Quattrone D, Di Forti M, Gayer-Anderson C, Ferraro L, JongsmaHE, Tripoli G, et al. Transdiagnostic dimensions of psychopathology atfirst episode psychosis: Findings from the multinational EU-GEI study.Psychological Medicine. 2019;49:1378-91. https://doi.org/10.1017/S0033291718002131

  28. Craddock M, Asherson P, Owen MJ, Williams J, McGuffin P, Farmer AE.Concurrent validity of the OPCRIT diagnostic system. Comparison ofOPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br JPsychiatry. 1996;169:58-63.

  29. Wiesinger GF, Nuhr M, Quittan M, Ebenbichler G, Wölfl G, Fialka-Moser V. Cross-cultural adaptation of the Roland-Morris questionnaire forGerman-speaking patients with low back pain. Spine. 1999;24:1099-103.

  30. Hutchinson A, Bentzen N, König-Zahn C. Cross-cultural health outcomeassessment: a user’s guide. Groningen: ERGHO, 1997.

  31. Landis JR, Koch GG. The measurement of observer agreement forcategorical data. Biometrics. 1977;33:159-174.

  32. Azevedo MH, Soares MJ, Coelho I, Dourado A, Valente J, Macedo A, etal. Using consensus OPCRIT diagnoses. An efficient procedure for best-estimatelifetime diagnoses. The British Journal of Psychiatry. 1999;175:154-7.https://doi.org/10.1192/bjp.175.2.154

  33. Martínez-Leal R, Soriano-Peña MF, Moreno-Küstner B. Falta de insighten la esquizofrenia. Cuadernos de Psiquiatría Comunitaria. 2004;4:146-58.

  34. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, et al. Schedulesfor Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry.1990;47:589-93. https://doi.org/10.1001/archpsyc.1990.01810180089012

  35. Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM.Best estimate of lifetime psychiatric diagnosis: a methodological study.Arch Gen Psychiatry. 1982;39:879-83.

  36. Serretti A, Lattuada E, Cusin C, Smeraldi E. Factor analysis of delusionaldisorder symptomatology. Compr Psychiatry. 1999;40:143-7. https://doi.org/10.1016/S0010-440X(99)90118-9

  37. Muñoz-Negro JE, Ibáñez-Casas I, de Portugal E, Lozano-Gutiérrez V,Martínez-Leal R, Cervilla JA. A Psychopathological Comparison betweenDelusional Disorder and Schizophrenia. Can J Psychiatry. 2018;63:12-19. https://doi.org/10.1177/0706743717706347

  38. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med.2012;22:276-82.

  39. Bujang MA, Baharum N. Guidelines of the minimum sample size requirementsfor Cohen’s Kappa. Epidemiol Biostat Public Health. 2017;14:1-10. https://doi.org/10.2427/12267




2020     |     www.medigraphic.com